DE3590855T1 - - Google Patents

Info

Publication number
DE3590855T1
DE3590855T1 DE19853590855 DE3590855T DE3590855T1 DE 3590855 T1 DE3590855 T1 DE 3590855T1 DE 19853590855 DE19853590855 DE 19853590855 DE 3590855 T DE3590855 T DE 3590855T DE 3590855 T1 DE3590855 T1 DE 3590855T1
Authority
DE
Germany
Prior art keywords
adenosine
increasing
coronary
humans
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19853590855
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SOLLMEDCO AB, BROMMA, SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25116698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3590855(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of DE3590855T1 publication Critical patent/DE3590855T1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE19853590855 1985-09-24 1985-10-29 Withdrawn DE3590855T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77951685A 1985-09-24 1985-09-24

Publications (1)

Publication Number Publication Date
DE3590855T1 true DE3590855T1 (de) 1988-08-25

Family

ID=25116698

Family Applications (4)

Application Number Title Priority Date Filing Date
DE3588205T Expired - Lifetime DE3588205T2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels für kontinuierliche Intravenöse Infusion an menschlichen Patienten
DE3586993T Expired - Fee Related DE3586993T3 (de) 1985-09-24 1985-10-29 Kontinuierliche intravenöse infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.
DE1999175044 Active DE19975044I2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten
DE19853590855 Withdrawn DE3590855T1 (de) 1985-09-24 1985-10-29

Family Applications Before (3)

Application Number Title Priority Date Filing Date
DE3588205T Expired - Lifetime DE3588205T2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels für kontinuierliche Intravenöse Infusion an menschlichen Patienten
DE3586993T Expired - Fee Related DE3586993T3 (de) 1985-09-24 1985-10-29 Kontinuierliche intravenöse infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.
DE1999175044 Active DE19975044I2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten

Country Status (9)

Country Link
EP (2) EP0275249B2 (de)
JP (1) JP2535504B2 (de)
AT (2) ATE84419T1 (de)
AU (1) AU613304B2 (de)
CA (1) CA1301652C (de)
DE (4) DE3588205T2 (de)
DK (1) DK253187A (de)
NZ (1) NZ217592A (de)
WO (1) WO1987001593A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002258A1 (en) * 1986-10-06 1988-04-07 The University Of Virginia Alumni Patents Foundati Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US6004945A (en) * 1990-05-10 1999-12-21 Fukunaga; Atsuo F. Use of adenosine compounds to relieve pain
US5256398A (en) * 1990-11-08 1993-10-26 Whitby Research, Inc. Composition for determining viability of tissue
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
CN103260670A (zh) 2010-10-15 2013-08-21 塞托弗尔克斯股份有限公司 细胞分离灌流器及其用途
JP2015504318A (ja) 2011-10-14 2015-02-12 サイトフェリックス インコーポレイテッド 心筋機能を向上させるためのカートリッジおよび方法
US20140350553A1 (en) * 2011-11-21 2014-11-27 Denerve Inc. Renal artery ablation catheter and system

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3133925A1 (de) * 1981-08-27 1983-03-17 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittel zur behandlung von hypertonie
EP0152944A2 (de) * 1984-02-23 1985-08-28 Roche Diagnostics GmbH Verwendung von Adenosin-Derivaten als Antiallergica und Arzneimittel, die diese enthalten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845205A (en) * 1970-06-04 1974-10-29 Univ Sydney 2-loweralkylthioadenosines
FR2129833B1 (de) * 1971-03-16 1974-08-02 Cerm Cent Europ Rech Mauvernay
ZA7468B (en) * 1973-01-16 1974-11-27 J Voorhees Compositions and treatment of proliferatave skin diseases with phosphodiesterase inhibitors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3133925A1 (de) * 1981-08-27 1983-03-17 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittel zur behandlung von hypertonie
EP0152944A2 (de) * 1984-02-23 1985-08-28 Roche Diagnostics GmbH Verwendung von Adenosin-Derivaten als Antiallergica und Arzneimittel, die diese enthalten

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Acta Physiologica Scandinavica 120, 1, S.171-176, 1984 *
Thoracie and cardiovascular Surpeojn, 30, 1, S.14-20, 1982 *

Also Published As

Publication number Publication date
DE3588205D1 (de) 1999-03-11
AU613304B2 (en) 1991-08-01
DE3588205T2 (de) 1999-06-02
DE3586993D1 (de) 1993-02-25
ATE84419T1 (de) 1993-01-15
EP0275249A1 (de) 1988-07-27
ATE176154T1 (de) 1999-02-15
DE3586993T2 (de) 1993-04-29
AU5065585A (en) 1987-04-07
JP2535504B2 (ja) 1996-09-18
DE19975044I2 (de) 2006-02-02
DK253187D0 (da) 1987-05-19
JPS63501497A (ja) 1988-06-09
DE3586993T3 (de) 1998-03-19
EP0275249B2 (de) 1997-12-17
DK253187A (da) 1987-05-19
EP0506205A1 (de) 1992-09-30
WO1987001593A1 (en) 1987-03-26
EP0506205B1 (de) 1999-01-27
NZ217592A (en) 1990-10-26
CA1301652C (en) 1992-05-26
EP0275249B1 (de) 1993-01-13

Similar Documents

Publication Publication Date Title
JPS6468279A (en) Pacemaker for the heart
IT8203369A0 (it) Elettrostimolatore cardiaco impiantabile,di tipo fisiologico, in cui la frequenza di stimolazione e'regolata dalla frequenza respiratoria del paziente
EP0235811A3 (en) Catheters for measurement of cardiac output and blood flow velocity
DE60238142D1 (de) Implantierbares system
ATE46267T1 (de) Dilatationskatheter mit doppeltem lumen.
SE7710575L (sv) Hjertstimulator
ATE223176T1 (de) Herzschrittmacher mit elektrode und integriertem sauerstoff-fühler
DE3590855T1 (de)
SE8506029L (sv) Hjert-lungsystem avsett for syresettning av en patients blod
NO882853D0 (no) Korreksjon med dobbeltraadet rna av unormale tilstander i immunkomplekser som er i omloep, og i monocytfunkjon.
PT86346A (en) Method of treatment by means of the 3:-deoxitimidinene-2:(3:deoxi-2:3:-didesidrotimidine) administration to animals of hot blood infected with retrovirus
DK63488D0 (da) Anvendelse af human blod-koagulationsfaktor xiii til behandling af ulcerativ colitis
Thomas et al. Circulatory, psychological & performance variables during 100 hours of paced continuous exercise under conditions of controlled energy intake & work output.
Landis et al. Automatic control for the artificial heart
Szatmary et al. Haemodynamic and antiischaemic protective effects of intra-aortic balloon counterpulsation in high risk coronary heart patients undergoing percutaneous transluminal coronary angioplasty
DE3470842D1 (en) Arrangement in a catheter unit with attachment wings, for infusion cannulas
EP0263174A4 (de) Erhöhte gefässperfusion nach verabreichung von lipiden.
DE3876425T2 (de) Gesteuerte verabreichung eines heilmittels an blut.
VETTES et al. Methods and major findings of cardiovascular exploration involving the human centrifuge
Visher Counseling stepfamilies.
IT8412421A1 (it) Elettrostimolatore cardiaco impiantabile, di tipo fisiologico, in cui le frequenza di stimolazione controllata dalla media della velocità di deformazione del torace causata dalla respirazione del paziente
Bonde-Petersen et al. Plasma catecholamines and central hemodynamics during simulated zero gravity(head out water immersion) in humans
Slósarska et al. Physiological reactivity of patients with endogenous and neurotic depression.
SOBOLEVSKIY Contrast temperatures in sauna as a means of enhancing man's orthostatic stability
Iwa et al. Positioning for simultaneous intracardiac repair and/or ascending aorta and descending aorta surgery

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8127 New person/name/address of the applicant

Owner name: SOLLMEDCO AB, BROMMA, SE

8128 New person/name/address of the agent

Representative=s name: WEBER, D., DIPL.-CHEM. DR.RER.NAT. SEIFFERT, K., D

8139 Disposal/non-payment of the annual fee